Hepatitis remains a significant public health concern, and nurses across all settings play a critical role in early recognition, patient education, prevention, and long-term management. Viral hepatitis A, B, C, D, and E differ in transmission, severity, and chronicity, yet all can cause substantial liver injury if not identified and managed effectively (CDC, 2024). Because nurses encounter hepatitis in acute care, ambulatory clinics, community health, long-term care, and school settings, a clear understanding of symptoms, diagnostics, medications, precautions, diet, psychosocial needs, and nuanced nursing considerations is essential.
Types of Hepatitis and Key Symptoms
Hepatitis presents in several viral forms, each with distinct transmission patterns and clinical features. Hepatitis A (HAV) spreads via the fecal-oral route, often through contaminated food or water, and typically causes an acute, self-limiting illness marked by fever, fatigue, anorexia, nausea, abdominal pain, dark urine, clay-colored stools, and jaundice (Mayo Clinic, 2025). Hepatitis B (HBV) is transmitted through blood and body fluids and may be acute or chronic; chronic infection significantly increases the risk of cirrhosis and hepatocellular carcinoma (Terrault et al., 2018). Common symptoms include jaundice, right upper quadrant pain, pruritus, malaise, and dark urine. Hepatitis C (HCV) is primarily bloodborne and has a high rate of chronic infection; it often remains asymptomatic until advanced disease develops, at which point patients may experience fatigue, mild abdominal discomfort, or late-stage manifestations such as jaundice or ascites (EASL, 2023). Hepatitis D (HDV) occurs only in individuals with HBV and is associated with more severe disease and faster progression (EASL, 2023). Hepatitis E (HEV), transmitted via the fecal-oral route, most commonly through contaminated water, usually causes an acute illness, though chronic infection can occur in immunocompromised individuals (World Health Organization [WHO], 2024).
Important Medications
Managing viral hepatitis requires nurses to understand not only the medications used but also the drug interactions and monitoring needs that directly affect patient safety. HAV and HEV are treated with supportive care alone, so nursing priorities focus on hydration, rest, nutrition, and avoiding hepatotoxic medications such as acetaminophen or certain herbal supplements (Mayo Clinic, 2025). HBV treatment commonly involves antivirals such as tenofovir or entecavir, which suppress viral replication and reduce long-term complications (Terrault et al., 2018). Nurses should closely monitor renal function in patients receiving tenofovir, as nephrotoxicity is a known risk, and assess for drug interactions with nephrotoxic agents such as NSAIDs and aminoglycosides. Entecavir should be taken on an empty stomach, and nurses should reinforce adherence, as missed doses increase the risk of viral resistance. HCV is treated with direct-acting antivirals (DAAs), such as sofosbuvir-based regimens, which cure more than 95% of infections within 8–12 weeks (EASL, 2023). DAAs have several clinically important interactions: sofosbuvir should not be co-administered with amiodarone due to life-threatening bradycardia, and many DAAs interact with antiepileptics, antiretrovirals, and acid-reducing agents. Nurses should review all medications, ensure consistent dosing, and educate patients that a cure does not prevent reinfection. HDV management focuses on controlling HBV, and interferon-based therapies may be used in select cases. These therapies require nurses to monitor for depression, flu-like symptoms, cytopenias, and thyroid dysfunction, all of which are common adverse effects (EASL, 2023). Across all hepatitis types, nurses play a central role in monitoring liver function tests, identifying medication toxicity early, reinforcing adherence, and educating patients about alcohol avoidance, safe medication use, and the importance of follow-up care.
Labs and Diagnostics to Monitor
Monitoring laboratory and diagnostic data is essential when caring for patients with suspected or confirmed hepatitis, as these results guide clinical decision-making and help nurses identify complications early. Routine liver function tests, including ALT, AST, bilirubin, and alkaline phosphatase, provide insight into the degree of hepatic inflammation or cholestasis (Mayo Clinic, 2025). Assessing synthetic function through INR and albumin helps determine whether the liver maintains adequate protein synthesis and coagulation capacity. Because several hepatitis treatments, particularly antivirals for HBV and some DAAs for HCV, carry a risk of nephrotoxicity, nurses should also monitor kidney function, including serum creatinine, BUN, and estimated GFR (Terrault et al., 2018). Viral serologies, such as HAV IgM, HBsAg, anti-HBs, anti-HBc, HCV antibody, and HCV RNA, help determine the type of infection, immune status, and viral replication (CDC, 2024). Imaging, especially ultrasound, is frequently used to evaluate fibrosis, ascites, biliary obstruction, or liver masses, while elastography or liver biopsy may be required to stage chronic hepatitis and assess the degree of fibrosis (WHO, 2024). Together, these diagnostics give nurses a comprehensive picture of liver and kidney health, enabling them to anticipate complications, monitor treatment response, and advocate for timely interventions.
Precautions Nurses Should Take
For nurses, maintaining strict infection-prevention practices when caring for patients with any form of hepatitis is essential. Consistent hand hygiene before and after every patient interaction remains one of the most effective ways to prevent transmission (CDC, 2024). Gloves should always be worn when there is potential contact with blood or body fluids, and nurses must adhere to safe injection practices, including using single-dose vials when possible and never reusing needles or syringes. Needle safety is a critical nursing responsibility. Needles should never be recapped, and safety devices must be activated immediately after use to prevent needlestick injuries. Any surface contaminated with blood or body fluids should be cleaned promptly with approved disinfectants to reduce environmental transmission. Because HBV poses a well-known occupational hazard, all nurses should have documented HBV vaccination and confirmed immunity (WHO, 2024). During procedures that carry a risk of splashing, such as blood draws, wound irrigation, or central line care, nurses should wear eye protection to safeguard mucous membranes and prevent exposure. These precautions protect the healthcare team and reinforce a culture of safety.
Diet Education for Patients
Diet plays a major role in supporting liver recovery and managing symptoms in patients with hepatitis. Patients should be advised to avoid alcohol completely, as even small amounts can worsen inflammation and accelerate liver damage (Mayo Clinic, 2025). Nurses should also encourage patients to limit acetaminophen and avoid hepatotoxic herbal supplements such as kava or comfrey. Because nausea and early satiety are common, small, frequent meals can help maintain adequate caloric intake. Adequate protein supports healing unless the patient is experiencing severe hepatic encephalopathy, in which case protein intake may need to be adjusted. A low-fat diet may benefit patients with steatorrhea or cholestasis, and maintaining adequate hydration is essential to prevent dehydration from nausea, vomiting, or diarrhea.
Psychosocial Care Considerations
Hepatitis often carries significant stigma, particularly for HBV and HCV, and nurses play a crucial role in creating a safe, supportive environment for patients. Nonjudgmental, trauma-informed communication builds trust and reduces shame. Nurses should remain attentive to signs of anxiety, depression, or guilt, as emotional distress is common and can affect engagement in care. Because hepatitis is frequently associated with intravenous drug use or other high-risk exposures, nurses should screen for substance use disorders and connect patients with harm-reduction resources or treatment programs (CDC, 2024). Many patients also face barriers related to insurance coverage, medication access, transportation, or follow-up, and nurses are often the first to identify these challenges and coordinate support. When appropriate, nurses can encourage family involvement by educating household contacts and ensuring they receive recommended vaccinations.
Nursing Considerations You Don’t Want to Miss
Nurses should remain vigilant for early signs of hepatic encephalopathy, such as sleep-wake reversal or subtle confusion, because these changes often precede overt symptoms and may signal worsening liver function. Pruritus management is essential, as persistent itching can disrupt sleep, reduce comfort, and lead to skin breakdown or infection. Thorough medication reconciliation is critical because many commonly used drugs, including acetaminophen, certain antibiotics, and herbal supplements, are hepatotoxic and can accelerate liver injury (Mayo Clinic, 2025). Nurses also play a key role in vaccination advocacy, particularly for HAV and HBV, as immunization remains one of the most effective strategies to prevent new infections (WHO, 2024). For patients with chronic HBV or HCV, long-term surveillance is essential; routine liver ultrasounds every six months help detect fibrosis progression or hepatocellular carcinoma at earlier, more treatable stages (EASL, 2023). In inpatient settings, nurses should reinforce the importance of avoiding the sharing of personal items, such as razors and toothbrushes, to prevent bloodborne transmission. Finally, maintaining privacy and confidentiality is crucial, as stigma surrounding hepatitis can discourage patients from seeking care or adhering to treatment.
References
Centers for Disease Control and Prevention. (2024). Viral hepatitis: Overview and statistics.
European Association for the Study of the Liver. (2023). EASL clinical practice guidelines: Hepatitis B and C management. Journal of Hepatology, 79(2), 345–389.
Mayo Clinic. (2025). Hepatitis: Symptoms, causes, and treatment.
Terrault, N. A., Lok, A. S., McMahon, B. J., Chang, K. M., Hwang, J. P., Jonas, M. M., & Brown, R. S. (2018). Update on prevention, diagnosis, and treatment of chronic hepatitis B. Hepatology, 67(4), 1560–1599.
World Health Organization. (2024). Hepatitis B and C: Key facts.
Let Life Sing
